Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 2,626–2,650 of 7,816 matching trials · page 106 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease NCT04886063 ATH-1017 Runs in: United States · 1 site |
PHASE2|PHASE3 other |
TERMINATED | 423 | LeonaBio INDUSTRY |
2025-04-01 |
|
Effect of Neuronavigated Theta-Burst Transcranial Magnetic Stimulation (TBS) for Early Alzheimer's Disease NCT06524817 transcranial magnetic stimulation Runs in: China · 1 site |
NA other |
WITHDRAWN | 0 | Anhui Medical University OTHER |
2025-04-01 |
|
Diagnosing Frontotemporal Lobar Degeneration NCT02964637 Observational Study Runs in: Canada · 1 site |
NA other |
RECRUITING | 100 | University Health Network, Toronto OTHER |
2025-03-30 |
|
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease NCT03019757 DaTscan; F18-AV-45; FDG-PET; APOE genotype; Polysomnogram; Clinical... Runs in: United States · 1 site |
NA other |
RECRUITING | 76 | Douglas Scharre OTHER |
2025-03-30 |
|
Resident-to-Resident Elder Mistreatment Intervention for Dementia Care in Assisted Living NCT03383289 R-REM training Runs in: United States · 1 site |
NA other |
COMPLETED | 930 | Hebrew Home at Riverdale OTHER |
2025-03-30 |
|
Detecting Early Alzheimer's Using MR NCT05614310 Magnetic Resonance Imaging (MRI); Blood Glucose Assessment; Positro... Runs in: United Kingdom · 1 site |
NA other |
RECRUITING | 60 | University of Aberdeen OTHER |
2025-03-30 |
|
Resilient Together for Dementia NCT06421545 Resilient Together for Dementia Runs in: United States · 1 site |
NA other |
COMPLETED | 12 | Icahn School of Medicine at Mount Sinai OTHER |
2025-03-30 |
|
Adaptation and Normalization of a Verbal Episodic Memory Test in French Sign Language NCT06902753 Questionnaire and Physical Exam |
NA other |
NOT_YET_RECRUITING | 120 | Poitiers University Hospital OTHER |
2025-03-30 |
|
A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants NCT04451408 LY3372993; Placebo Runs in: Japan; United States · 13 sites |
PHASE1 other |
COMPLETED | 139 | Eli Lilly and Company INDUSTRY |
2025-03-28 |
|
VR&R: Providing Caregiver Respite by Managing BPSDs and Improving QoL in People with Dementia Using Immersive VR-Therapy NCT05867641 Immersive VR Therapy in Head-Mounted Display (HMD) (Solo); Immersiv... Runs in: Canada · 7 sites |
NA other |
RECRUITING | 50 | University Health Network, Toronto OTHER |
2025-03-28 |
|
Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey NCT06025877 PrecivityAD2(TM) blood test Runs in: United States · 9 sites |
NA other |
UNKNOWN | 400 | C2N Diagnostics INDUSTRY |
2025-03-28 |
|
DMB-I in the Treatment of Alzheimer Type Dementia NCT06292351 DMB-I (Dimebon); Placebo Runs in: Russia · 7 sites |
PHASE2 other |
COMPLETED | 133 | Bigespas LTD INDUSTRY |
2025-03-28 |
|
Gut Microbiome and Blood Indices in Patients With AD and Their Spousal Caregivers NCT05601856 Runs in: United States · 1 site |
NA other |
UNKNOWN | 104 | University of Virginia OTHER |
2025-03-27 |
|
Pimavanserin and Aggression and Social Cognition. NCT05895513 Pimavanserin 34 mg; Placebo Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 35 | Ohio State University OTHER |
2025-03-27 |
|
Diagnostic Evaluation of Dementia with Lewy Bodies Using a Multimodal Approach NCT06068361 EEG Runs in: France · 1 site |
NA other |
RECRUITING | 130 | Assistance Publique - Hôpitaux de Paris OTHER |
2025-03-27 |
|
Language Intervention Training for Cognitive Protection in High-risk Cardio-Cerebrovascular Elderly Population NCT06898931 Dialect Interpreting Training |
NA other |
NOT_YET_RECRUITING | 80 | Second Affiliated Hospital, Zhejiang University, School of Medicine OTHER |
2025-03-27 |
|
The Effect of Horticultural Activities on Physical and Cognitive Status, Mental Well-Being, Social Participation and Quality of Life in Individuals Diagnosed with Dementia NCT06899256 Horticultural Activity Program Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 40 | Hacettepe University OTHER |
2025-03-27 |
|
Memory and Antioxidants in Vascular Impairment Trial NCT03306979 N Acetylcysteine; Placebo oral capsule Runs in: Canada · 1 site |
PHASE2 other |
COMPLETED | 60 | Sunnybrook Health Sciences Centre OTHER |
2025-03-26 |
|
A Mobile Informatics Solution to Aid in Memory NCT04700540 Smartwatch Reminder (SR) system Runs in: United States · 1 site |
NA other |
COMPLETED | 162 | University of Minnesota OTHER |
2025-03-26 |
|
A Pilot Study on App-based Treatment Combining Physical Exercise, Graded Activity, and Pain Journaling for Patients with Spinal Complaints NCT06896812 The app-based treatment consists of a combination of physical exerc... |
NA other |
NOT_YET_RECRUITING | 30 | Zuyderland Medisch Centrum OTHER |
2025-03-26 |
|
Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE) NCT02544074 neuropsychological testing; eSAGE testing Runs in: United States · 1 site |
NA other |
COMPLETED | 69 | Ohio State University OTHER |
2025-03-25 |
|
Understanding Cerebral Blood Flow Dynamics for Alzheimer's Disease Prevention Through Exercise NCT06584656 Aerobic exercise condition; Resistance exercise condition Runs in: Spain · 2 sites |
NA other |
COMPLETED | 20 | Universidad de Granada OTHER |
2025-03-25 |
|
Monitoring of Brain Metabolites Using Proton and Deuterium MR Techniques NCT06705010 Application of new pulse sequence package SIGNATURES2023 to healthy... Runs in: Switzerland · 1 site |
NA other |
NOT_YET_RECRUITING | 140 | Insel Gruppe AG, University Hospital Bern OTHER |
2025-03-25 |
|
Holistic Integration for Healthy Longevity and Aging in Place NCT06882434 Local intervention program; Referral Process; Telehealth Education ... |
NA other |
NOT_YET_RECRUITING | 600 | National Taiwan University Hospital OTHER |
2025-03-25 |
|
AMPER Proof of Concept Study NCT06894953 Personalised Agent-based Memory Prosthesis to Encourage Reminiscing... Runs in: United Kingdom · 1 site |
NA other |
NOT_YET_RECRUITING | 40 | University of Strathclyde OTHER |
2025-03-25 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial